Pharmacology Flashcards
vitamin D analogs
e.g. calcipotriene (calcipotriol), calcitriol, tacalcitol
bind and activate vitamin D receptor (a nuclear TF) –> inhibition of keratinocyte proliferation, stimulation of keratinocyte differentiation, inhibits TC proliferation and other inflammatory mediators
bottom line: anti-inflammatory that is used to tx things like psoriasis
cyclosporine
inhibits NFAT (nuclear factor of activated TCs) –> impairs production and release of IL2 and IL2 induced TC activation
bottom line: anti-inflammatory that is used to tx things like psoriasis
Etanercept
recombinant form of TNF receptor that binds TNF-a
bottom line: anti-inflammatory that is used to tx things like psoriasis, RA, psoriatic arthritis
MTX
folate antimetabolite that reversibly binds to dihydrofolate reductase resulting in inhibition of purine and thymidylic acid synthesis
Ustekinumab
human monoclonal Ab targeting IL-12 and IL-23 –> inhibits activation of CD4 Th1 and Th17 cells
Foscarnet
pyrophosphate analog
indication: ganciclovir-resistant CMV
side effects: Ca chelation, renal wasting of Mg, dec release of PTH
Acyclovir
crystal nephropathy and neurotoxicity manifesting as delirium and/or tremor
Cidofovir
indication: CMV retinitis
side effects: nephrotoxicity (proteinuria and inc Cr)
Lamivudine
NRTI
side effects: rare, occasionally peripheral neuropathy and lactic acidosis
Sofosbuvir
inhibits nonstructural protein 5B, RNA-dependent RNA polymerase needed for HCV replication
Indication: HCV
SE: fatigue, nausea
Valganciclovir
ganciclovir prodrug
SE: severe neutropenia exacerbated by other BM suppressants (eg zidovudine, trimethoprim-sulfamethoxazole)
Ganciclovir
can cause severe neutropenia exacerbated by other BM suppressants (eg zidovudine, trimethoprim-sulfamethoxazole)
Loop diuretics
eg furosemide, bumetanide, torsemide
hypoK, hypoMg, hypoCa, ototoxicity
Thiazide diuretics
eg chlorthalidone, hydrochlorothiazide
act at distal convoluted tubule causing enhanced Na, Cl, and H2O excretion by blocking Na Cl symporters in DCT
hypoK, hypoNa, hyperuricemia, hypercalcemia
K+ sparing diuretics
eg triamterene, sprionolactone
act at collecting duct system
SE: hyperK
Spironolactone: gynecomastia, antiandrogen effects
Carbonic anhydrase inhibitors
eg acetazolamide
act at PCT and straight portion to block reabsorption of NaHCO3
SE: metabolic acidosis
Osmotic diuretics
eg mannitol
act at proximal tubule and descending limb of Loop of Henle to reduce Na and H2O reabsorption
SE: hyperNa, pulmonary edema
Metronidazole
tx anaerobic infections
indictations:
- mild to moderate cases of c. diff (i.e. first and first recurrence)
- Giardia lamblia
- entamoeba histolytica
- trichomonas vaginalis
more extensive absorption so less it delivered to distal colon than vanc and fidaxomicin
vancomycin
po for severe or recurrent c. diff colitis
bactericidal except at doses used to tx c. diff
- binds to terminal D-alanine residues of cell wall glycoproteins and prevents transpeptidases from forming cross-links
minimal systemic absorption
Fidaxomicin
macrocyclic abx
inhibits sigma subunit of RNA pol –> protein synthesis impairment and cell death
i.e. bacteriocidal activity
Advantages:
- minimal systemic absorption
- less effect on normal colonic flora than vanc or metronidazole
Doxycycline indications
clostridial skin infections (C perfringens, C septicum)
Neomycin
bacteriocidal
indications:
- hepatic encephalopathy
- diarrhea 2/2 e. coli
- surgical pphx for GI procedures
chloroquine
tx of choice for sensitive plasmodium species
mefloquine
quinine analog
tx for chloroquine-resistant organisms
Primaquine
given for P. vivax and P. ovale with hypnozoites in addition to chloroquine or mefloquine
Ivermectin
tx for onchocerciasis (river blindness)
Mebendazole
anti-helminthic drug
indications:
- ascariasis
- trichuriasis
- hookworm
- pinworm infections
Nifurtimox
antiparasitic tx Chagas dz (American trypanosomiasis) caused by Trypanosoma cruzi
Pentamidine
- pphyx for PCP PNA
- tx African sleeping sickness and leishmaniasis
Statin severe side effects
- hepatitis
- myopathy (i.e. serum CPK 10x normal and muscle pain) –> especially when combined with fibrates like gemfibrozil and fenofibrate bc they inc statin concentration
- simvastatin = highest risk of myopathy, dose not to exceed 10 mg when concurrently giving fibrates
statin MoA
HMG-CoA redutase inhibitor
bile acid sequestrants can dec its absorption therefore dose at least 4 hrs apart
ezetimibe
dec cholesterol absorption in small intestine
inc risk of myopathy when given with statin but less than when statin given with fibrate
penicillin and cephalosporin MoA
irreversibly bind penicillin-binding proteins, e.g. transpeptidases which normally cross-link peptidoglycan in bacterial cell wall –> leads to cell wall instability and bacteriolysis
diff bacT species synthesize multiple diff penicillin-binding proteins
fluoroquinolones MoA
interfere with DNA replication by binding proteins like DNA gyrase in bacT (akin to topoisomerase II)
Macrolide MoA
binds ribosomal proteins
tetracyclines MoA
binds 30S ribosomal subunit preventing attachment of aminoacyl-tRNA
beta-lactamases
degrade penicillin and cephalosporins thereby preventing binding to pencillin-binding proteins
CTX resistance
structural changes in penicillin-binding proteins
Trimethoprim-sulfamethoxazole resistance
salvage metabolic pathway that circumvents metabolic pathway targeted by drug
Tetracyline and marcrolide resistance
transmembranous efflux pumps that prevent entry into the cell
aminoglycosides MoA
binds 30S and inhibits formation of initiation complex and causes misreading of mRNA
Chloramphenicol MoA
binds 50S and inhibits peptidyl transferase
macrolide MoA
binds 50S and prevents release of uncharged tRNA after it has donated its amino acid
Hydroxyurea
inhibits ribonucleotide reductase interfering with purine synthesis
6-mercaptopurine (6-MP)
blocks de novo purine synthesis
tx gout
5-fluorouracil (5-FU)
inhibits thymidylate synthase (decreases deoxythymidine monophosphate dTMP) interfering with purine synthesis
Methotrexate
inhibits dihydrofolate reductase (decreases dTMP) interfering with purine synthesis
Trimethoprim
inhibits bacterial dihydrofolate reductase (dec dTMP) interfering with purine synthesis
Trazodone
antidepressant
MoA =inhibits 5HT reuptake, alpha-adrenergic blockade, histamine H1 receptor antagonism
side effects = priapism (rare but severe), orthostatic HoTN, sedation
use cautiously when pt has condition predisposing to priapism = sickle cell, multiple myeloma
Tricyclic antidepressants
2nd line therapy
SE = cardiotoxicity
clomipramine = for OCD
Monoamine oxidase inhibitors
dietary restrictions bc of risk for hypertensive crisis (tyrosine, cheese)
Phenelzine = tx of resistant depression
SSRIs
sexual side effects = dec libido, anorgasmia, delayed ejaculation
SNRI
eg duloxetine
Zolpidem
non-benzo hypnotic used to tx insomnia
Clopidogrel
inhibits ADP-induced platelet aggregation
ACEi
tx of CHF, HTN, diabetic nephropathy
Indomethacin
non-specific COX inhibitor –> suppresses prostaglandin synthesis
promotes closure of PDA
Bosentan
competitive endothelin receptor antagonist used to tx idiopathic pulmonary arterial htn
vincristine
vinca alkaloid (also vinblastine)
MoA = inhibits microtubule formation by binding beta-tubulin and preventing polymerization
cell cycle-specific cytotoxicity during M phase (chromosomes can’t align and segregate)
toxicity = dose-dependent, most commonly PERIPHERAL NEUROPATHY
*chemotox man –> arms and legs
Topoisomerase I and II inhibitors
chemo drugs = irinotecan and etoposide
bleomycin
chemotherapeutic targeting G2 phase of cell cycle
MoA = intercalates with DNA and induces free radical formation
SE = lung fibrosis
doxorubicin
chemotherapeutic targeting G2 phase of cell cycle
MoA = intercalates with DNA and induces free radical formation
SE = irreversible dose-induced cardiomyopathy
cell-cycle nonspecific chemotherapeutic agents
cyclophosphamide = alkylating agent; SE include BM suppression, alopecia, hemorrhagic cystitis
Rifampin
inhibits bacT DNA-dependent RNA pol –> blocks DNA transcription
side effects: GI, Rash, Red-orange body fluids, cytopenia
Isoniazid
inhibits mycolic acid synthesis
mycolic acids normally cause mycobacteria to be acid-fast bc they retain the carbofuchsin dye and resist decoloration by acid-alcohol decolorizing agent –> when isoniazid inhibits it, it loses its acid-fast coloration and stop synthesizing new cell walls/proliferating
SE: neurotoxicity (give B6/pyridoxine), hepatotoxicity
Pyrazinamide
unclear MoA
SE: hepatotoxicity, hyperuricemia
Ethambutol
inhibition of arabinosyl transferase
SE: optic neuropathy
Amphotericin B
most toxic antifungal
tx for disseminated histoplasmosis
nephrotoxicity c/b dec in GFR and toxic effects on tubular epithelium –> increased permeability of distal tubule –> hypoK, hypoMg –> weakness and arrhythmias –> EKG shows T wave flattening, ST depression, U waves, PAC, PVC –> profound hypoK get vtach or vfib
glucocorticoids and osteoporosis
- inc osteoclast differentiation and activity
- dec osteoblast activity
- inhibiting intestinal action of Vit D in promoting Ca absorption
- inc PTH levels
occurs if taken daily for >6 mo
can also occur with topical intake, eg inhaler
Meds associated with osteoporosis
- anticonvulsants that induce CYP450 - phenobarb, phenytoin, carbamazepine. inc vit D catabolism
- aromatase inhibitors - dec estrogen
- medroxyprogesterone - “
- GnRH agonists - dec testosterone and estrogen
- PPIs - dec Ca absorption
- unfractionated heparin - dec bone formation
- glucocorticoids - “
- thiazolidinediones - “
Tx for hyperammonemia
benzoate or phenylbutyrate = bind aa and lead to excretion
lactulose = acidifies GI tract and traps NH4+ so you poop it out
volume of distribution (Vd)
Vd = amount of drug in body / plasma drug concentration
theoretical fluid volume required to maintain total absorbed drug amount at the plasma concentration
Vd of plasma protein-bound drug can be altered by liver and kidney disease (dec protein binding inc Vd)
half-life (t1/2)
0.7 x Vd
________
Clearance
a drug infused at a constant rate takes 4-5 half-lives to reach steady state
Clearance (CL)
rate of drug elimination = Vd x Ke (elimination constant)
____________________
plasma drug concentration
Loading dose
Cp X Vd / F
Cp = target plasma concentration
Maintenance dose
Cp x CL / F
Zero-order elimination
constant amount of drug-eliminated per unit time
Cp dec linearly with time
e. g. PEA (round like 0)
- Phenytoin
- Ethanol
- Aspirin
First-order elimination
constant fraction of drug eliminated per unit time
Cp dec exponentially with time